uniQure NV (QURE)
6.055
+0.48
(+8.71%)
USD |
NASDAQ |
Nov 05, 16:00
6.055
0.00 (0.00%)
After-Hours: 20:00
uniQure Enterprise Value: -150.68M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | -150.68M |
| November 01, 2024 | -136.56M |
| October 31, 2024 | -143.37M |
| October 30, 2024 | -114.88M |
| October 29, 2024 | -109.28M |
| October 28, 2024 | -96.62M |
| October 25, 2024 | -103.68M |
| October 24, 2024 | -106.36M |
| October 23, 2024 | -108.55M |
| October 22, 2024 | -98.08M |
| October 21, 2024 | -100.52M |
| October 18, 2024 | -109.28M |
| October 17, 2024 | -116.10M |
| October 16, 2024 | -106.85M |
| October 15, 2024 | -147.27M |
| October 14, 2024 | -147.27M |
| October 11, 2024 | -146.78M |
| October 10, 2024 | -157.98M |
| October 09, 2024 | -148.73M |
| October 08, 2024 | -133.63M |
| October 07, 2024 | -162.36M |
| October 04, 2024 | -146.78M |
| October 03, 2024 | -199.86M |
| October 02, 2024 | -200.84M |
| October 01, 2024 | -196.94M |
| Date | Value |
|---|---|
| September 30, 2024 | -181.84M |
| September 27, 2024 | -174.54M |
| September 26, 2024 | -179.65M |
| September 25, 2024 | -187.20M |
| September 24, 2024 | -171.62M |
| September 23, 2024 | -176.00M |
| September 20, 2024 | -160.90M |
| September 19, 2024 | -145.81M |
| September 18, 2024 | -141.42M |
| September 17, 2024 | -148.24M |
| September 16, 2024 | -158.47M |
| September 13, 2024 | -146.29M |
| September 12, 2024 | -152.14M |
| September 11, 2024 | -155.55M |
| September 10, 2024 | -163.34M |
| September 09, 2024 | -160.42M |
| September 06, 2024 | -157.98M |
| September 05, 2024 | -152.63M |
| September 04, 2024 | -158.47M |
| September 03, 2024 | -150.68M |
| August 30, 2024 | -137.04M |
| August 29, 2024 | -119.02M |
| August 28, 2024 | -126.57M |
| August 27, 2024 | -125.84M |
| August 26, 2024 | -123.89M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-288.31M
Minimum
Oct 27 2023
2.892B
Maximum
Jan 09 2020
789.22M
Average
710.80M
Median
Apr 05 2023
Enterprise Value Benchmarks
| ProQR Therapeutics NV | 198.19M |
| Merus NV | 2.874B |
| argenx SE | 32.06B |
| Pharming Group | 488.90M |
| Pharvaris NV | 926.83M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -56.30M |
| Revenue (Quarterly) | 11.13M |
| Total Expenses (Quarterly) | 55.14M |
| EPS Diluted (Quarterly) | -1.16 |
| Gross Profit Margin (Quarterly) | 32.94% |
| Profit Margin (Quarterly) | -506.0% |
| Earnings Yield | -97.94% |
| Normalized Earnings Yield | -97.39 |